Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Nanoemulgel improves delivery and effectiveness of plant-based drugs for various conditions.

A special treatment speeds up chronic wound healing by fixing cell energy issues and reversing aging in cells.

The new treatment using nanoparticles with ISX9 can effectively regrow hair without major side effects.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Exosome therapies could help with skin and hair issues, but more testing is needed.

Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.

A man developed skin issues from cancer medication, which improved with specific treatments.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Patient care should come before profit in medicine.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

New peptides can delay aging and improve cell function.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Pharmacists play a crucial role in improving patient outcomes through personalized care and staying updated with scientific advancements.